Lv5
920 积分 2023-01-13 加入
Long-Term Efficacy and Safety of Stapokibart in Adults with Moderate-to-Severe Atopic Dermatitis: An Open-Label Extension, Nonrandomized Clinical Trial
6个月前
已完结
[Treatment of refractory chronic cough: current status and prospects]
6个月前
已完结
[Guidelines for the prevention and management of bronchial asthma (2024 edition)]
7个月前
已完结
Efficacy and Safety of Extending Dosing Interval of Stapokibart in Patients with Atopic Dermatitis
7个月前
已完结
B细胞靶向药物治疗风湿免疫病中国专家共识（2024版）
7个月前
已完结
Stapokibart for Severe Uncontrolled Chronic Rhinosinusitis With Nasal Polyps
8个月前
已完结
皖公网安备34019202002308
